Predilife Valuation
| ALPRE Stock | EUR 4.36 0.08 1.87% |
At this time, the company appears to be overvalued. Predilife holds a recent Real Value of €3.58 per share. The prevailing price of the company is €4.36. Our model determines the value of Predilife from analyzing the company fundamentals such as Gross Profit of (3.52 M), return on asset of -0.57, and Shares Outstanding of 3.64 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Predilife's price fluctuation is relatively risky at this time. Calculation of the real value of Predilife is based on 3 months time horizon. Increasing Predilife's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Predilife's intrinsic value may or may not be the same as its current market price of 4.36, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.36 | Real 3.58 | Hype 4.28 | Naive 4.23 |
The intrinsic value of Predilife's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Predilife's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Predilife helps investors to forecast how Predilife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Predilife more accurately as focusing exclusively on Predilife's fundamentals will not take into account other important factors: Predilife Total Value Analysis
Predilife is presently projected to have takeover price of 22.91 M with market capitalization of 22.6 M, debt of 4.52 M, and cash on hands of 94.9 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Predilife fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.91 M | 22.6 M | 4.52 M | 94.9 K |
Predilife Investor Information
The company recorded a loss per share of 0.86. Predilife had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Predilife's historical financial statements, Predilife is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Predilife Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Predilife has an asset utilization ratio of 4.94 percent. This connotes that the Company is making €0.0494 for each dollar of assets. An increasing asset utilization means that Predilife is more efficient with each dollar of assets it utilizes for everyday operations.Predilife Profitability Analysis
The company reported the revenue of 195.9 K. Net Loss for the year was (3.41 M) with loss before overhead, payroll, taxes, and interest of (3.52 M).About Predilife Valuation
The stock valuation mechanism determines Predilife's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Predilife based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Predilife. We calculate exposure to Predilife's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Predilife's related companies.Predilife S.A. develops and sells medical techniques and mathematical models. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France. PREDILIFE is traded on Paris Stock Exchange in France.
8 Steps to conduct Predilife's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Predilife's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Predilife's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Predilife's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Predilife's revenue streams: Identify Predilife's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Predilife's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Predilife's growth potential: Evaluate Predilife's management, business model, and growth potential.
- Determine Predilife's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Predilife's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Predilife Stock Analysis
When running Predilife's price analysis, check to measure Predilife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predilife is operating at the current time. Most of Predilife's value examination focuses on studying past and present price action to predict the probability of Predilife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predilife's price. Additionally, you may evaluate how the addition of Predilife to your portfolios can decrease your overall portfolio volatility.